Agustin Iskandar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Agustin Iskandar has a total of 110 co-authors. Here are the top co-authors by number of shared publications:
- Titin Andri Wihastuti
Brawijaya University
6 shared publications - Mohammad Saifur Rohman
Brawijaya Cardiovascular Research Center, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
5 shared publications - Bayu Lestari
Division of Cardiovascular Sciences, University of Manchester, Manchester M13 9PL, UK
4 shared publications - Delvac Oceandy
University of Manchester
4 shared publications - Djanggan Sargowo
Department of Cardiology and Vascular Medicine, Faculty of Medicine, Brawijaya University, Malang 65145, Indonesia
4 shared publications - Efta Triastuti
Department of Pharmacy, Faculty of Medicine, Brawijaya University, Malang 65145, Indonesia
4 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by UK Scientific Publishing Limited in Trends in Immunotherapy
- Vol. 10 (3) , 122-132
Pilot Randomized Trial of Vitamin D and Zinc Supplementation on Total Adenosine Deaminase in Pediatric Tuberculosis
Pediatric tuberculosis remains difficult to monitor using objective biomarkers. Total serum adenosine deaminase (ADA) reflects cellular immune activation, whereas vitamin D and zinc may modify antimycobacterial immunity. This pilot randomized trial evaluated whether adjunctive vitamin D or zinc altered serum ADA during the intensive phase of pediatric tuberculosis treatment. Thirty-three treatment-naive children with tuberculosis were randomized equally to standard anti-tuberculosis treatment (ATT) alone, ATT plus zinc, or ATT plus vitamin D. Total serum ADA was measured at baseline and after two months. The prespecified completer analysis compared change scores, while the primary adjusted analysis used analysis of covariance (ANCOVA) with post-treatment ADA as the outcome and baseline ADA as a covariate. A multiple-imputation intention-to-treat sensitivity analysis included all randomized participants. Twenty-two participants completed follow-up (ATT, n = 8; zinc, n = 8; vitamin D, n = 6). Unadjusted ADA decreased in all groups and most markedly in the vitamin D arm, but the between-group difference in change was not significant (p = 0.364). Baseline-adjusted ANCOVA also showed no treatment-group difference (F2,18 = 0.79; p = 0.470). Compared with ATT alone, the adjusted effects were −4.35 U/L for vitamin D (95% CI −15.70 to 7.00) and +2.26 U/L for zinc (95% CI −8.07 to 12.59). The intention-to-treat sensitivity analysis produced the same overall interpretation. In this underpowered pilot trial, adjunctive vitamin D or zinc did not significantly reduce total serum ADA beyond standard therapy. The large crude decline in the vitamin D arm was attenuated after adjustment for baseline imbalance and regression to the mean. Larger multicentre trials should confirm micronutrient repletion, measure ADA2, and prespecify methods for missing data.
- 1 September 2026
- Published by UK Scientific Publishing Limited in Trends in Immunotherapy
- Vol. 10 (3) , 122-132
Open AccessPilot Randomized Trial of Vitamin D and Zinc Supplementation on Total Adenosine Deaminase in Pediatric Tuberculosis
Pediatric tuberculosis remains difficult to monitor using objective biomarkers. Total serum adenosine deaminase (ADA) reflects cellular immune activation, whereas vitamin D and zinc may modify antimycobacterial immunity. This pilot randomized trial evaluated whether adjunctive vitamin D or zinc altered serum ADA during the intensive phase of pediatric tuberculosis treatment. Thirty-three treatment-naive children with tuberculosis were randomized equally to standard anti-tuberculosis treatment (ATT) alone, ATT plus zinc, or ATT plus vitamin D. Total serum ADA was measured at baseline and after two months. The prespecified completer analysis compared change scores, while the primary adjusted analysis used analysis of covariance (ANCOVA) with post-treatment ADA as the outcome and baseline ADA as a covariate. A multiple-imputation intention-to-treat sensitivity analysis included all randomized participants. Twenty-two participants completed follow-up (ATT, n = 8; zinc, n = 8; vitamin D, n = 6). Unadjusted ADA decreased in all groups and most markedly in the vitamin D arm, but the between-group difference in change was not significant (p = 0.364). Baseline-adjusted ANCOVA also showed no treatment-group difference (F2,18 = 0.79; p = 0.470). Compared with ATT alone, the adjusted effects were −4.35 U/L for vitamin D (95% CI −15.70 to 7.00) and +2.26 U/L for zinc (95% CI −8.07 to 12.59). The intention-to-treat sensitivity analysis produced the same overall interpretation. In this underpowered pilot trial, adjunctive vitamin D or zinc did not significantly reduce total serum ADA beyond standard therapy. The large crude decline in the vitamin D arm was attenuated after adjustment for baseline imbalance and regression to the mean. Larger multicentre trials should confirm micronutrient repletion, measure ADA2, and prespecify methods for missing data.
- Open Access
- 2 June 2026
- Published by Taylor & Francis in All Life
- Vol. 19 (1)
Prognostic utility of combined suPAR and procalcitonin levels for mortality prediction in sepsis patients
- 2 June 2026
- Published by Taylor & Francis in All Life
- Vol. 19 (1)
Open AccessPrognostic utility of combined suPAR and procalcitonin levels for mortality prediction in sepsis patients
- Open Access
- 8 January 2026
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 198 (3) , 1869-1898
Phytochemical Analysis of Different Plant Organs of Bauhinia kockiana Korth. and Its Antibacterial Synergistic Interaction
The rise of antimicrobial resistance (AMR) necessitates novel natural therapeutics. Combining plant extracts offers a promising strategy to enhance antibacterial efficacy via synergistic, multi-target interactions. Bauhinia kockiana, a medicinal vine traditionally used for various treatments, exhibits promising antimicrobial properties, yet the synergistic potential of its multi-organ extracts remains unexplored. This study evaluated the phytochemical profiles and antibacterial activities of aqueous extracts against Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa. Liquid chromatography-mass spectrometry (LC–MS) and Fourier-transform infrared spectroscopy (FTIR) identified 10 organ-specific bioactive phytocompounds and characterized their functional groups. The flower extracts demonstrated the highest total phenolic and flavonoid contents, correlating with superior antibacterial activity. Disc diffusion assays revealed concentration-dependent effects, with flower extracts outperforming streptomycin against MRSA. Minimum inhibitory concentrations (MICs) ranged from 0.125 – 0.5% w/v, with flower extracts showing bactericidal effects against MRSA and P. aeruginosa. Checkerboard assays and well diffusion assays confirmed synergistic flower-stem interactions across multiple pathogens. This combination significantly inhibited S. aureus biofilm formation (> 50% at sub-MIC, complete at 2MIC) and induced morphological deformation. Time–kill kinetics confirmed concentration-dependent bactericidal effects, and mechanistic studies indicated membrane disruption as a primary mode of action, evidenced by enhanced cytoplasmic and protein leakage. These findings highlight the therapeutic potential of B. kockiana multi-organ extracts for combinatorial strategies to combat AMR sustainably.
- 8 January 2026
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 198 (3) , 1869-1898
Open AccessPhytochemical Analysis of Different Plant Organs of Bauhinia kockiana Korth. and Its Antibacterial Synergistic Interaction
The rise of antimicrobial resistance (AMR) necessitates novel natural therapeutics. Combining plant extracts offers a promising strategy to enhance antibacterial efficacy via synergistic, multi-target interactions. Bauhinia kockiana, a medicinal vine traditionally used for various treatments, exhibits promising antimicrobial properties, yet the synergistic potential of its multi-organ extracts remains unexplored. This study evaluated the phytochemical profiles and antibacterial activities of aqueous extracts against Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa. Liquid chromatography-mass spectrometry (LC–MS) and Fourier-transform infrared spectroscopy (FTIR) identified 10 organ-specific bioactive phytocompounds and characterized their functional groups. The flower extracts demonstrated the highest total phenolic and flavonoid contents, correlating with superior antibacterial activity. Disc diffusion assays revealed concentration-dependent effects, with flower extracts outperforming streptomycin against MRSA. Minimum inhibitory concentrations (MICs) ranged from 0.125 – 0.5% w/v, with flower extracts showing bactericidal effects against MRSA and P. aeruginosa. Checkerboard assays and well diffusion assays confirmed synergistic flower-stem interactions across multiple pathogens. This combination significantly inhibited S. aureus biofilm formation (> 50% at sub-MIC, complete at 2MIC) and induced morphological deformation. Time–kill kinetics confirmed concentration-dependent bactericidal effects, and mechanistic studies indicated membrane disruption as a primary mode of action, evidenced by enhanced cytoplasmic and protein leakage. These findings highlight the therapeutic potential of B. kockiana multi-organ extracts for combinatorial strategies to combat AMR sustainably.
- Open Access
- 5 January 2026
- Published by UK Scientific Publishing Limited in Trends in Immunotherapy
- p. 1-12
Macrophage Migration Inhibitory Factor as a Biomarker of Severe Dengue and Shock in Children: A Cross-Sectional Study in Indonesia
Dengue remains a leading cause of child mortality in Indonesia. Identifying reliable biomarkers to predict disease severity is essential for early intervention. Macrophage Migration Inhibitory Factor (MIF) is a pro-inflammatory cytokine involved in the pathogenesis of dengue. This study aimed to assess the relationship between MIF levels and dengue severity in children, and to compare the predictive value of MIF levels with C-Reactive Protein (CRP) and serum albumin levels. A cross-sectional study was conducted on 104 pediatric dengue patients hospitalized at Saiful Anwar General Hospital. Serum levels of MIF (ELISA), CRP, and albumin were measured upon admission. Patients were categorized into four severity grades (Grade 1–4) and also stratified into shock and non-shock groups. Statistical analyses included ANOVA, correlation analysis, and receiver operating characteristic (ROC) curve evaluation. MIF levels showed a significant stepwise increase with disease severity and were significantly higher in patients with shock (p < 0.001). CRP levels were also elevated in severe dengue, but the correlation with severity was moderate (r = 0.61, p < 0.05). In contrast, serum albumin levels were inversely associated with severity (r = –0.67, p < 0.05), with lower values observed in the shock group. ROC analysis demonstrated that MIF had the highest predictive accuracy for shock (AUC = 0.94), compared to CRP (AUC = 0.78) and albumin (AUC = 0.81). MIF is a robust biomarker for predicting dengue severity and shock in children, outperforming CRP and albumin in diagnostic performance. The integration of MIF with conventional markers may improve early risk stratification and clinical decision-making in pediatric dengue.
- 5 January 2026
- Published by UK Scientific Publishing Limited in Trends in Immunotherapy
- p. 1-12
Open AccessMacrophage Migration Inhibitory Factor as a Biomarker of Severe Dengue and Shock in Children: A Cross-Sectional Study in Indonesia
Dengue remains a leading cause of child mortality in Indonesia. Identifying reliable biomarkers to predict disease severity is essential for early intervention. Macrophage Migration Inhibitory Factor (MIF) is a pro-inflammatory cytokine involved in the pathogenesis of dengue. This study aimed to assess the relationship between MIF levels and dengue severity in children, and to compare the predictive value of MIF levels with C-Reactive Protein (CRP) and serum albumin levels. A cross-sectional study was conducted on 104 pediatric dengue patients hospitalized at Saiful Anwar General Hospital. Serum levels of MIF (ELISA), CRP, and albumin were measured upon admission. Patients were categorized into four severity grades (Grade 1–4) and also stratified into shock and non-shock groups. Statistical analyses included ANOVA, correlation analysis, and receiver operating characteristic (ROC) curve evaluation. MIF levels showed a significant stepwise increase with disease severity and were significantly higher in patients with shock (p < 0.001). CRP levels were also elevated in severe dengue, but the correlation with severity was moderate (r = 0.61, p < 0.05). In contrast, serum albumin levels were inversely associated with severity (r = –0.67, p < 0.05), with lower values observed in the shock group. ROC analysis demonstrated that MIF had the highest predictive accuracy for shock (AUC = 0.94), compared to CRP (AUC = 0.78) and albumin (AUC = 0.81). MIF is a robust biomarker for predicting dengue severity and shock in children, outperforming CRP and albumin in diagnostic performance. The integration of MIF with conventional markers may improve early risk stratification and clinical decision-making in pediatric dengue.
- Open Access
- 2 January 2026
- Published by Taylor & Francis in Journal of Oral Microbiology
- Vol. 18 (1)
Transition of oral microbiome profile in HIV-infected Indonesian patients: the role of antiretroviral therapy
HIV infection alters host immunity, including the oral environment, leading to microbial imbalance and increased risk of opportunistic infections. Although antiretroviral therapy (ART) improves immune function, its effect on the oral microbiome remains unclear, particularly in Indonesia. This study investigated oral microbiome composition in people living with HIV and its associations with ART status, age, and sex. In this cross-sectional study, oral rinse samples from 245 adults (115 HIV-on-ART, 15 HIV-ART-naïve, and 115 HIV-negative controls) were analysed using 16S rRNA gene sequencing. Alpha and beta diversity metrics, differential abundance (ANCOM-BC2), and multivariable associations (PERMANOVA) were assessed. The oral microbiome differed significantly between HIV-positive groups and controls (PERMANOVA p = 0.001, R² = 1.8%). HIV-ART-naïve individuals exhibited the highest alpha diversity and enrichment of pro-inflammatory genera, including Fusobacterium, Alloprevotella, and Staphylococcus. ART-treated individuals displayed a partial shift toward the control profile but retained persistent depletion of bacteria such as Filifactor and (Eubacterium) saphenum. Multivariate analysis identified HIV status, age, and sex as independent contributors to microbial variation. HIV infection is associated with a distinct oral dysbiosis characterised by an increase in opportunistic pathogens and reduction in commensal bacteria. HIV-on-ART individuals show a transitional shift towards the HIV-negative oral microbiome profiles. Our findings suggest that biological and/or demographic factors coupled to oral microbiome profiles may facilitate targeted interventions in the personalised management of oral health for individuals living with HIV.
- 2 January 2026
- Published by Taylor & Francis in Journal of Oral Microbiology
- Vol. 18 (1)
Open AccessTransition of oral microbiome profile in HIV-infected Indonesian patients: the role of antiretroviral therapy
HIV infection alters host immunity, including the oral environment, leading to microbial imbalance and increased risk of opportunistic infections. Although antiretroviral therapy (ART) improves immune function, its effect on the oral microbiome remains unclear, particularly in Indonesia. This study investigated oral microbiome composition in people living with HIV and its associations with ART status, age, and sex. In this cross-sectional study, oral rinse samples from 245 adults (115 HIV-on-ART, 15 HIV-ART-naïve, and 115 HIV-negative controls) were analysed using 16S rRNA gene sequencing. Alpha and beta diversity metrics, differential abundance (ANCOM-BC2), and multivariable associations (PERMANOVA) were assessed. The oral microbiome differed significantly between HIV-positive groups and controls (PERMANOVA p = 0.001, R² = 1.8%). HIV-ART-naïve individuals exhibited the highest alpha diversity and enrichment of pro-inflammatory genera, including Fusobacterium, Alloprevotella, and Staphylococcus. ART-treated individuals displayed a partial shift toward the control profile but retained persistent depletion of bacteria such as Filifactor and (Eubacterium) saphenum. Multivariate analysis identified HIV status, age, and sex as independent contributors to microbial variation. HIV infection is associated with a distinct oral dysbiosis characterised by an increase in opportunistic pathogens and reduction in commensal bacteria. HIV-on-ART individuals show a transitional shift towards the HIV-negative oral microbiome profiles. Our findings suggest that biological and/or demographic factors coupled to oral microbiome profiles may facilitate targeted interventions in the personalised management of oral health for individuals living with HIV.
- Open Access
- 24 December 2025
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 15 (6) , 1111-1120
Predictive utility of monocyte chemoattractant Protein-1 (MCP-1) and D-dimer in risk stratification of sepsis: a prospective cohort study
Background. Sepsis is a severe and life-threatening clinical syndrome characterized by a dysregulated host immune response to infection. This maladaptive response promotes widespread endothelial injury and abnormalities in coagulation, often progressing to multi-organ dysfunction and death. Mortality rates remain high, highlighting the urgent need for reliable biomarkers to enable early identification of patients at high risk. Such tools are particularly valuable in low- and middle-income countries (LMICs), where access to advanced diagnostic and therapeutic resources is limited. Monocyte Chemoattractant Protein-1 (MCP-1) is a chemokine that reflects hyperactivation of the innate immune system, while D-dimer indicates activation of coagulation and fibrinolysis. Although both pathways are central to the pathophysiology of sepsis, data evaluating their combined prognostic value in LMIC settings remain scarce. This study aimed to assess the prognostic significance of MCP-1 and D-dimer, both individually and in combination, for predicting 28-day mortality in patients with sepsis. Materials and methods. We conducted a prospective cohort study involving 83 adult patients with newly diagnosed sepsis at Dr. Saiful Anwar General Hospital, Malang, Indonesia. Serum MCP-1 levels were measured using enzyme-linked immunosorbent assay (ELISA), and plasma D-dimer levels were determined by immunoturbidimetry at the time of diagnosis. Patients were followed for 28 days, and survival outcomes were evaluated using Kaplan–Meier survival analysis and Cox proportional hazards regression models. Results. Among the 83 participants, 58 patients (70%) died within 28 days. Non-survivors demonstrated significantly higher MCP-1 and D-dimer levels compared with survivors. An MCP-1 concentration ≥ 123.03 pg/mL was strongly associated with increased mortality (HR 2.664, p = 0.005). Elevated D-dimer (≥ 43.5 mg/L FEU) showed a weaker individual association, but when combined with MCP-1, predictive accuracy for mortality was significantly enhanced (HR 3.986, p = 0.037). Conclusion. The concurrent elevation of MCP-1 and D-dimer identifies patients with sepsis who are at markedly increased risk of death. These findings support the potential utility of integrating inflammatory and coagulation biomarkers for early risk stratification. Moreover, they highlight the central role of the inflammation–coagulation axis in sepsis pathophysiology, with particular relevance for clinical practice in resource-limited settings.
- 24 December 2025
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 15 (6) , 1111-1120
Open AccessPredictive utility of monocyte chemoattractant Protein-1 (MCP-1) and D-dimer in risk stratification of sepsis: a prospective cohort study
Background. Sepsis is a severe and life-threatening clinical syndrome characterized by a dysregulated host immune response to infection. This maladaptive response promotes widespread endothelial injury and abnormalities in coagulation, often progressing to multi-organ dysfunction and death. Mortality rates remain high, highlighting the urgent need for reliable biomarkers to enable early identification of patients at high risk. Such tools are particularly valuable in low- and middle-income countries (LMICs), where access to advanced diagnostic and therapeutic resources is limited. Monocyte Chemoattractant Protein-1 (MCP-1) is a chemokine that reflects hyperactivation of the innate immune system, while D-dimer indicates activation of coagulation and fibrinolysis. Although both pathways are central to the pathophysiology of sepsis, data evaluating their combined prognostic value in LMIC settings remain scarce. This study aimed to assess the prognostic significance of MCP-1 and D-dimer, both individually and in combination, for predicting 28-day mortality in patients with sepsis. Materials and methods. We conducted a prospective cohort study involving 83 adult patients with newly diagnosed sepsis at Dr. Saiful Anwar General Hospital, Malang, Indonesia. Serum MCP-1 levels were measured using enzyme-linked immunosorbent assay (ELISA), and plasma D-dimer levels were determined by immunoturbidimetry at the time of diagnosis. Patients were followed for 28 days, and survival outcomes were evaluated using Kaplan–Meier survival analysis and Cox proportional hazards regression models. Results. Among the 83 participants, 58 patients (70%) died within 28 days. Non-survivors demonstrated significantly higher MCP-1 and D-dimer levels compared with survivors. An MCP-1 concentration ≥ 123.03 pg/mL was strongly associated with increased mortality (HR 2.664, p = 0.005). Elevated D-dimer (≥ 43.5 mg/L FEU) showed a weaker individual association, but when combined with MCP-1, predictive accuracy for mortality was significantly enhanced (HR 3.986, p = 0.037). Conclusion. The concurrent elevation of MCP-1 and D-dimer identifies patients with sepsis who are at markedly increased risk of death. These findings support the potential utility of integrating inflammatory and coagulation biomarkers for early risk stratification. Moreover, they highlight the central role of the inflammation–coagulation axis in sepsis pathophysiology, with particular relevance for clinical practice in resource-limited settings.
- Open Access
- 20 June 2025
- Published by Paediatrica Indonesiana - Indonesian Pediatric Society in Paediatrica Indonesiana
- Vol. 65 (3) , 463-70
Identifying key clinical markers for congenital cytomegalovirus infections: a PCR-confirmed case-control study
Background Congenital cytomegalovirus (CCMV) infection is the leading cause of congenital infections worldwide. Clinical manifestations of CCMV are highly variable and make the clinical diagnosis difficult, especially in settings where advanced diagnostic tools are not available. Objective To identify a cluster of clinical manifestations indicative of CCMV and analyze for correlations with PCR-confirmed diagnoses. Methods This case-control study was conducted at a tertiary care hospital in Malang, East Java, and included 40 neonates clinically suspected to have CCMV. PCR specimens from urine or saliva were collected and analyzed to evaluate clinical manifestations of suspected CCMV. Demographic and clinical data were organized and analyzed using SPSS. Results Of neonates with suspected CCMV, 32.5% (n=13) had PCR-confirmed CCMV. The median age for PCR testing post-suspected CCMV was 8.50 (range 3.75 to 24.25) days. Significant correlations emerged between PCR-confirmed CCMV and symptoms such as microcephaly, jaundice, purpura, thrombocytopenia, acute liver injury, hepatomegaly, feeding difficulties, and anemia. However, seizures, low birth weight, ventriculomegaly, and intrauterine growth restriction did not show significant associations, indicating their limited utility as solitary markers for CCMV. The clinical symptoms associated with CCMV were confirmed by PCR, emphasizing the significance of certain sign and symptom clusters, such as microcephaly with thrombocytopenia (OR 41.60; P<0.001), or the traditional triad of jaundice, purpura, and hepatosplenomegaly/acute liver injury (OR 41.60; P<0.001). Conclusion Several clinical manifestations are significantly associated with PCR-confirmed CCMV infection, underscoring the diagnostic value of specific symptom combinations in identifying CCMV infection. These combinations are microcephaly and thrombocytopenia and the classic triad of jaundice, purpura, and hepatosplenomegaly/acute liver injury.
- 20 June 2025
- Published by Paediatrica Indonesiana - Indonesian Pediatric Society in Paediatrica Indonesiana
- Vol. 65 (3) , 463-70
Open AccessIdentifying key clinical markers for congenital cytomegalovirus infections: a PCR-confirmed case-control study
Background Congenital cytomegalovirus (CCMV) infection is the leading cause of congenital infections worldwide. Clinical manifestations of CCMV are highly variable and make the clinical diagnosis difficult, especially in settings where advanced diagnostic tools are not available. Objective To identify a cluster of clinical manifestations indicative of CCMV and analyze for correlations with PCR-confirmed diagnoses. Methods This case-control study was conducted at a tertiary care hospital in Malang, East Java, and included 40 neonates clinically suspected to have CCMV. PCR specimens from urine or saliva were collected and analyzed to evaluate clinical manifestations of suspected CCMV. Demographic and clinical data were organized and analyzed using SPSS. Results Of neonates with suspected CCMV, 32.5% (n=13) had PCR-confirmed CCMV. The median age for PCR testing post-suspected CCMV was 8.50 (range 3.75 to 24.25) days. Significant correlations emerged between PCR-confirmed CCMV and symptoms such as microcephaly, jaundice, purpura, thrombocytopenia, acute liver injury, hepatomegaly, feeding difficulties, and anemia. However, seizures, low birth weight, ventriculomegaly, and intrauterine growth restriction did not show significant associations, indicating their limited utility as solitary markers for CCMV. The clinical symptoms associated with CCMV were confirmed by PCR, emphasizing the significance of certain sign and symptom clusters, such as microcephaly with thrombocytopenia (OR 41.60; P<0.001), or the traditional triad of jaundice, purpura, and hepatosplenomegaly/acute liver injury (OR 41.60; P<0.001). Conclusion Several clinical manifestations are significantly associated with PCR-confirmed CCMV infection, underscoring the diagnostic value of specific symptom combinations in identifying CCMV infection. These combinations are microcephaly and thrombocytopenia and the classic triad of jaundice, purpura, and hepatosplenomegaly/acute liver injury.
- Open Access
- 28 March 2025
- Published by UK Scientific Publishing Limited in Trends in Immunotherapy
- Vol. 9 (2) , 107-117
Presepsin and Mortality Risk in Sepsis: A Valuable Tool for Predicting Patient Survival
Background: Early identification of high-risk sepsis patients is essential for timely intervention and improved survival. Prognostic biomarkers can support clinical decision-making by stratifying mortality risk and informing treatment choices. Sepsis remains a major global health challenge due to its complex management and high mortality rate. Presepsin, a soluble CD14 subtype (sCD14-ST), has emerged as a promising biomarker for sepsis prognosis, demonstrating superior predictive value compared to conventional markers like procalcitonin (PCT). This study aims to evaluate the prognostic significance of Presepsin in predicting mortality among sepsis patients. Methods: A prospective cohort study was conducted on 110 adult sepsis patients admitted to the ICU at Dr. Saiful Anwar Hospital, Malang, from November 2018 to October 2019. Patients were diagnosed using the Sepsis-3 criteria, and Presepsin levels were measured using the chemiluminescent immunoassay (CLIA) method. Survival analysis was performed using Kaplan-Meier curves, and hazard ratios (HR) were calculated through Cox regression. Results: The ROC analysis identified 17,085 pg/mL as the optimal Presepsin threshold for predicting mortality (AUC: 0.939, 95% CI: 0.897–0.982, p < 0.001). Patients with Presepsin levels ≥17,085 pg/mL had a significantly lower median survival (3 days) compared to those with lower levels (9 days) (HR 3.654, 95% CI: 1.978–6.752, p < 0.001). Among patients with high Presepsin levels, 32 of 33 (96.9%) died, whereas only 28 of 77 (36.4%) patients with lower levels experienced mortality. Conclusion: Presepsin shows potential as a biomarker for identifying sepsis patients at increased risk of mortality. Its use may support early risk stratification and guide clinical decision-making in sepsis management.
- 28 March 2025
- Published by UK Scientific Publishing Limited in Trends in Immunotherapy
- Vol. 9 (2) , 107-117
Open AccessPresepsin and Mortality Risk in Sepsis: A Valuable Tool for Predicting Patient Survival
Background: Early identification of high-risk sepsis patients is essential for timely intervention and improved survival. Prognostic biomarkers can support clinical decision-making by stratifying mortality risk and informing treatment choices. Sepsis remains a major global health challenge due to its complex management and high mortality rate. Presepsin, a soluble CD14 subtype (sCD14-ST), has emerged as a promising biomarker for sepsis prognosis, demonstrating superior predictive value compared to conventional markers like procalcitonin (PCT). This study aims to evaluate the prognostic significance of Presepsin in predicting mortality among sepsis patients. Methods: A prospective cohort study was conducted on 110 adult sepsis patients admitted to the ICU at Dr. Saiful Anwar Hospital, Malang, from November 2018 to October 2019. Patients were diagnosed using the Sepsis-3 criteria, and Presepsin levels were measured using the chemiluminescent immunoassay (CLIA) method. Survival analysis was performed using Kaplan-Meier curves, and hazard ratios (HR) were calculated through Cox regression. Results: The ROC analysis identified 17,085 pg/mL as the optimal Presepsin threshold for predicting mortality (AUC: 0.939, 95% CI: 0.897–0.982, p < 0.001). Patients with Presepsin levels ≥17,085 pg/mL had a significantly lower median survival (3 days) compared to those with lower levels (9 days) (HR 3.654, 95% CI: 1.978–6.752, p < 0.001). Among patients with high Presepsin levels, 32 of 33 (96.9%) died, whereas only 28 of 77 (36.4%) patients with lower levels experienced mortality. Conclusion: Presepsin shows potential as a biomarker for identifying sepsis patients at increased risk of mortality. Its use may support early risk stratification and guide clinical decision-making in sepsis management.
- Open Access
- 28 March 2025
- Published by UK Scientific Publishing Limited in Trends in Immunotherapy
- Vol. 9 (2) , 60-72
The Relationship of Vitamin D and IL-17 Levels with Disease Severity in Pediatric Tuberculosis Patients
Tuberculosis (TB) remains a significant global health burden, particularly in children, where immune responses play a crucial role in disease progression. The objective of this research was to analyze the relationship of vitamin D and IL-17 levels with the severity of pediatric TB. This observational analytic study was conducted at Dr. Saiful Anwar Hospital, Malang, involving 33 pediatric patients diagnosed with TB, divided into mild (n = 8), moderate (n = 18) and severe (n = 7) groups. Severity was determined using the score developed in this study. Vitamin D levels were measured using the Cobas c501 analyzer, and IL-17 levels were measured using the Human IL-17 ELISA Kit. While Vitamin D level was significantly lower in microbiologically confirmed patients (p = 0.038), it was not significantly different among severity groups (p = 0.799). Meanwhile, IL-17 levels were significantly higher in patients with more severe respiratory distress (p = 0.01), although the difference between severity groups was not statistically significant (p = 0.966). Furthermore, there was no correlation between vitamin D levels and IL-17 levels (r = 0.178, p = 0.322). These findings indicate the need for further research to explore vitamin D supplementation as an adjunctive therapy and to evaluate IL-17 as a biomarker for disease activity.
- 28 March 2025
- Published by UK Scientific Publishing Limited in Trends in Immunotherapy
- Vol. 9 (2) , 60-72
Open AccessThe Relationship of Vitamin D and IL-17 Levels with Disease Severity in Pediatric Tuberculosis Patients
Tuberculosis (TB) remains a significant global health burden, particularly in children, where immune responses play a crucial role in disease progression. The objective of this research was to analyze the relationship of vitamin D and IL-17 levels with the severity of pediatric TB. This observational analytic study was conducted at Dr. Saiful Anwar Hospital, Malang, involving 33 pediatric patients diagnosed with TB, divided into mild (n = 8), moderate (n = 18) and severe (n = 7) groups. Severity was determined using the score developed in this study. Vitamin D levels were measured using the Cobas c501 analyzer, and IL-17 levels were measured using the Human IL-17 ELISA Kit. While Vitamin D level was significantly lower in microbiologically confirmed patients (p = 0.038), it was not significantly different among severity groups (p = 0.799). Meanwhile, IL-17 levels were significantly higher in patients with more severe respiratory distress (p = 0.01), although the difference between severity groups was not statistically significant (p = 0.966). Furthermore, there was no correlation between vitamin D levels and IL-17 levels (r = 0.178, p = 0.322). These findings indicate the need for further research to explore vitamin D supplementation as an adjunctive therapy and to evaluate IL-17 as a biomarker for disease activity.
- Open Access
- 25 March 2025
- Published by International Association of Online Engineering (IAOE) in International Journal of Online and Biomedical Engineering (iJOE)
- Vol. 21 (04) , 79-98
High Performance of LSTM on Dengue Shock Syndrome Detection Using DNA Sequence Encoding Methods
Dengue fever (DF) is a significant global health challenge, affecting approximately 390 million people annually and imposing substantial public health and economic burdens. Accurate DNA sequence classification is crucial for identifying genetic factors in diseases such as DF. However, many machine learning (ML) models for disease detection rely on basic encoding methods such as one-hot encoding, which fail to fully exploit the sequential and contextual nature of DNA data. To address this limitation, this study applies long short-term memory (LSTM) networks, a neural architecture adept at handling sequential data, to classify DNA sequences for detecting dengue and dengue shock syndrome (DSS). The study evaluates three encoding techniques— one-hot encoding, term frequency-inverse document frequency (TF-IDF), and Word2Vec— using datasets of 3,458 DNA sequences sourced from genomics repositories. Preprocessing included the removal of non-ACGT sequences and duplicates to ensure data integrity, followed by under-sampling to address class imbalance. Experimental results demonstrate that the LSTM model with Word2Vec encoding achieved the highest accuracy (0.98), significantly outperforming other encoding techniques. Word2Vec captures contextual and semantic relationships within DNA sequences, enabling superior classification performance. These findings highlight the potential of combining advanced encoding techniques with LSTM networks to improve the accuracy of disease detection models. The study’s approach offers promising implications for genomic diagnostics, particularly in resource-limited settings, and lays the foundation for future research into applying similar methodologies to other diseases or datasets.
- 25 March 2025
- Published by International Association of Online Engineering (IAOE) in International Journal of Online and Biomedical Engineering (iJOE)
- Vol. 21 (04) , 79-98
Open AccessHigh Performance of LSTM on Dengue Shock Syndrome Detection Using DNA Sequence Encoding Methods
Dengue fever (DF) is a significant global health challenge, affecting approximately 390 million people annually and imposing substantial public health and economic burdens. Accurate DNA sequence classification is crucial for identifying genetic factors in diseases such as DF. However, many machine learning (ML) models for disease detection rely on basic encoding methods such as one-hot encoding, which fail to fully exploit the sequential and contextual nature of DNA data. To address this limitation, this study applies long short-term memory (LSTM) networks, a neural architecture adept at handling sequential data, to classify DNA sequences for detecting dengue and dengue shock syndrome (DSS). The study evaluates three encoding techniques— one-hot encoding, term frequency-inverse document frequency (TF-IDF), and Word2Vec— using datasets of 3,458 DNA sequences sourced from genomics repositories. Preprocessing included the removal of non-ACGT sequences and duplicates to ensure data integrity, followed by under-sampling to address class imbalance. Experimental results demonstrate that the LSTM model with Word2Vec encoding achieved the highest accuracy (0.98), significantly outperforming other encoding techniques. Word2Vec captures contextual and semantic relationships within DNA sequences, enabling superior classification performance. These findings highlight the potential of combining advanced encoding techniques with LSTM networks to improve the accuracy of disease detection models. The study’s approach offers promising implications for genomic diagnostics, particularly in resource-limited settings, and lays the foundation for future research into applying similar methodologies to other diseases or datasets.